Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05952687
Title Trial of Idasanutlin and Selinexor Therapy for Children With Progressive/Relapsed AT/RT or Extra-CNS Malignant Rhabdoid Tumors
Recruitment Withdrawn
Gender
Phase Phase I
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications
Therapies
Age Groups: child | adult
Covered Countries


No variant requirements are available.